Kenneth I. Berns, PhD
Affiliations: | University of Florida, Gainesville, Gainesville, FL, United States |
Google:
"Kenneth Berns"Parents
Sign in to add mentor| Charles A. Thomas | grad student | Johns Hopkins Medical School (Chemistry Tree) |
Children
Sign in to add trainee| William W. Hauswirth | grad student | UF Gainesville | |
| Robert M. Kotin | grad student | UF Gainesville | |
| R. Michael Linden | grad student | UF Gainesville | |
| Arun Srivastava | grad student | UF Gainesville | |
| Shyam Daya | grad student | 2009 | UF Gainesville |
| Jude Samulski | post-doc | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Berns KI, Srivastava A. (2019) Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases. Gastroenterology Clinics of North America. 48: 319-330 |
| Berns KI, Muzyczka N. (2017) AAV: AN OVERVIEW OF UNANSWERED QUESTIONS. Human Gene Therapy |
| Berns KI, Byrne BJ, Flotte TR, et al. (2015) Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? Human Gene Therapy. 26: 779-81 |
| Muzyczka N, Berns KI. (2015) AAV's Golden Jubilee. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 807-8 |
| Berns KI. (2013) My life with adeno-associated virus: a long time spent studying a short genome. Dna and Cell Biology. 32: 342-7 |
| Linden RM, Berns KI. (2010) Viral Vectors for Gene Therapy Topley and Wilson's Microbiology and Microbial Infections |
| Daya S, Cortez N, Berns KI. (2009) Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway. Journal of Virology. 83: 11655-64 |
| Daya S, Berns KI. (2008) Gene therapy using adeno-associated virus vectors. Clinical Microbiology Reviews. 21: 583-93 |
| Zhang C, Cortez NG, Berns KI. (2007) Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration. Human Gene Therapy. 18: 787-97 |
| Brantly ML, Spencer LT, Humphries M, et al. (2006) Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Human Gene Therapy. 17: 1177-86 |